Salidur

Method of action: Diuretic

Treatment option: Ascites, Congestive Heart Failure, Edema, Heart Failure

Medically reviewed

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Salidur

Quick Facts

Property	Description
Active ingredient	Furosemide, Triamterene
Form	Oral Tablets (Comprimidos)
Pharmacological class	Combination Diuretic (Potassium-sparing and Loop)
Common use	Fluid removal and blood pressure management
Origin	Synthetic compound

What Type of Medicine is Salidur? (Definition and Classification)

Salidur is a synthetic, prescription-only medication officially classified as a combination diuretic, formulated for oral administration as tablets. This preparation represents a fixed-dose combination product containing two different types of active diuretic agents. The core purpose of its dual composition is to achieve potent fluid removal while maintaining electrolyte balance, a distinguishing feature of this pharmacological approach. This method of combination therapy illustrates the clinical application of pairing a loop diuretic with a potassium-sparing agent.

Composition: Furosemide and Triamterene Combination (Ingredients and Form)

The active ingredients of Salidur are Furosemide and Triamterene. Furosemide is classified as a Loop diuretic, known for its action in the kidney to promote the elimination of sodium ions (Na^+) and water. Triamterene, in contrast, is a Potassium-sparing diuretic that conserves essential potassium ions (K^+) by inhibiting sodium reabsorption in a different area of the renal tubules. The medication is designed as Oral Tablets (Comprimidos), offering a standardized method for patients to manage their therapy.

General Purpose: Fluid Control and Blood Pressure (High-Level Benefit)

The general therapeutic purpose of the Salidur combination is the restoration of fluid homeostasis through efficient diuresis (increased urine production). By compelling the kidneys to eliminate a larger volume of salt and water, the medication reduces the total fluid volume circulating in the body’s tissues and vascular system. This reduction in volume contributes directly to an antihypertensive effect, assisting in the overall control of arterial hypertension by lessening the mechanical load on the cardiovascular system. A typical application is the management of patients experiencing significant fluid accumulation when single-agent diuretics are insufficient or result in potassium loss.

What side effects are possible with Salidur?

Official Safety Profile and Adverse Reactions

The safety profile of Salidur, a combination diuretic containing Furosemide and Triamterene, is categorized by regulatory bodies based on the frequency and the physiological system affected. The most common adverse outcomes relate directly to its function of fluid removal and include changes in fluid volume and electrolyte balance.

Common and Clinically Significant Adverse Reactions

Adverse reactions classified as Very Common or Common in regulatory documents often involve the body’s metabolic and vascular systems. Very common effects include hyponatraemia (low sodium), hypochloraemic metabolic alkalosis, and hypotension (low blood pressure). The dual nature of the medication, combining a loop diuretic with a potassium-sparing agent, means the risk profile includes both hypokalemia (low potassium) and the possibility of hyperkalemia (high potassium).

Other documented common effects include hypovolaemia (reduced blood volume), increases in serum creatinine and blood urea, and metabolic changes such as hyperglycaemia and hyperuricaemia (elevated uric acid).

System-Organ Class	Examples of Documented Adverse Reactions
Metabolism & Nutrition	Various electrolyte imbalances, hyperuricaemia, impaired glucose tolerance
Vascular Disorders	Hypotension, orthostatic intolerance, vasculitis
Gastrointestinal	Nausea, vomiting, diarrhoea, acute pancreatitis (rare)

Serious Adverse Reactions and Safety Constraints

Rare but serious adverse reactions documented in official labeling include excessive fluid loss leading to circulatory collapse, vascular thrombosis and embolism, and severe skin conditions like Toxic Epidermal Necrolysis and Stevens-Johnson syndrome. Irreversible deafness has also been reported as a rare, serious event.

Safety documents also detail specific constraints. The medication is contraindicated in individuals with severe pre-existing conditions such as anuria, severe dehydration or hypovolaemia, severe electrolyte imbalances (e.g., severe hypokalaemia), and hepatic coma or pre-coma. Furthermore, older adults are officially noted as being particularly susceptible to adverse outcomes related to excessive diuresis.

Overdose and Emergency Response

Overdose and When to Seek Help

Salidur overdose is a serious medical emergency that requires immediate intervention due to the risk of life-threatening events. The official profile for this drug highlights the potential for severe central nervous system (CNS) and respiratory depression.

Overdose presentations documented in regulatory reports include:

Life-Threatening Respiratory Depression: Characterized by slowed, shallow, or difficult breathing, which can lead to lack of oxygen and be fatal.
Profound Central Nervous System Depression: This can manifest as severe drowsiness, stupor, an inability to wake up, or coma.
Cardiovascular and Musculoskeletal Effects: May include low blood pressure (hypotension), circulatory collapse, and significant skeletal muscle flaccidity.

When Immediate Medical Help is Required

Seek emergency medical help immediately if you suspect an overdose or accidental ingestion, even if the person appears only mildly affected. Any signs of respiratory compromise (slowed or shallow breathing), unresponsiveness, or profound sleepiness are critical red flags.

Accidental ingestion of even one dose, particularly by a child, may result in a fatal overdose and must be treated as an immediate emergency. Clinical management protocols described in the drug labeling include ensuring a patent airway, providing assisted or controlled ventilation, and the administration of a specific antagonist medication, if indicated and available, to reverse the severe effects.

Therapeutic Uses of Salidur

What Salidur Treats: Main Uses and Benefits

Salidur is a medication used to provide essential symptomatic support by addressing certain challenging symptoms and conditions where temporary assistance is required to manage heightened discomfort. It is applied in therapeutic domains where supportive symptom management is appropriate, as symptomatic treatments generally focus on relieving signs and symptoms for the patient's comfort and well-being. Salidur is commonly used in contexts requiring short-term relief during acute phases.

Easing the Burden of Pronounced Symptoms

Salidur is applied to manage symptom intensity when manifestations become pronounced or difficult to tolerate, addressing groups of symptoms related to heightened physiological activity. It is relevant in conditions characterized by episodic or fluctuating symptom patterns, or those involving acute or disruptive episodes, where short-term symptomatic assistance is needed. The medication provides support that helps ease the overall symptom load.

“Salidur is relevant in contexts marked by increased discomfort or tension where additional symptomatic support is needed.”

Supporting Functional Stability

This medication is used in situations where symptoms interfere with daily functioning and create temporary functional strain. It assists with coping during difficult episodes. It may assist patients with maintaining functional stability when acute manifestations disrupt routine activities. The common scenarios of use include managing symptoms that intensify and addressing discomfort during phases of increased distress.

Quick Fact: Supports the management of Symptoms that Interfere with Daily Functioning

Regulatory References

NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility Status for Salidur

Salidur is intended for use in adult patients (18 years and older) who do not have documented absolute contraindications. The drug's population eligibility is strictly defined by government regulatory authorities, primarily concerning the patient's existing health status and age.

Eligibility Classification	Population / Condition
Contraindicated	Anuria (no urine production), Severe Renal Failure, Hyperkalemia (high potassium levels), or Hypersensitivity to Furosemide, Triamterene, or sulfonamide-derived drugs.
Not Recommended	Pediatric patients (safety and effectiveness are not established); Pregnancy; and Lactation (components are excreted into human milk).
Use with Caution	Patients with Hepatic Impairment (risk of hepatic coma), Diabetes Mellitus, Gout or Hyperuricemia, and older adults (due to increased susceptibility to fluid/electrolyte changes).

Age-Related Eligibility Rules: Use is not recommended for children and adolescents because safety and efficacy have not been established. Dosage for older adults requires caution and close monitoring.

Connection to the overall eligibility profile: Regulatory documents define non-eligibility through absolute contraindications related to organ function (severe renal failure) and critical electrolyte status (hyperkalemia). Restrictions are also imposed on vulnerable populations where safety data are officially lacking or risks are elevated.

What should I know about interactions with other medicines?

Salidur's interaction profile is strictly defined by official regulatory documentation focusing on two core risks: potassium balance disruption and enhanced organ toxicity. Co-administration with other potassium-sparing diuretics (such as Spironolactone) and all forms of potassium supplementation is formally contraindicated due to the high risk of severe hyperkalemia stemming from the Triamterene component. Furosemide-related restrictions mandate avoiding concurrent use of Ethacrynic acid and Aminoglycoside antibiotics due to a documented increase in the potential for ototoxicity.

Pharmacodynamic and Exposure Interactions

Pharmacodynamic interactions include the risk of severe hypotension and deterioration of renal function when Salidur is combined with Renin-Angiotensin System inhibitors. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) may antagonize the diuretic effect and increase the risk of nephrotoxicity. Furthermore, the combination reduces the renal clearance of Lithium, leading to a high potential for toxicity.

Regulatory documents specify mandatory timing rules to manage drug exposure: Sucralfate must not be administered within two hours of Furosemide, and a two-to-three-hour separation is advised for Colestyramine or Colestipol. Co-administration with a high-fat meal is documented to significantly increase the bioavailability of the Triamterene component. In patients with Hypoproteinemia (e.g., nephrotic syndrome), the ototoxicity of Furosemide may be potentiated.

Mechanism of Action

Dual Inhibition of Renal Salt and Water Reabsorption

The mechanism of Salidur focuses on disrupting key ion transport in two different segments of the renal tubule to achieve substantial fluid excretion. Furosemide acts as a high-capacity blocker of the Na^+- K^+- Cl^- Cotransporter 2 ( NKCC2) in the Loop of Henle, preventing the reabsorption of a substantial fraction of filtered salt and water. This molecular blockade initiates a pronounced natriuresis (sodium excretion) and diuresis, leading to a reduction in the total Extracellular Fluid Volume (ECFV).

Complementary Potassium Conservation Mechanism

This second domain addresses the final stage of electrolyte handling to modulate the resulting changes in electrolyte balance. Triamterene functions as an inhibitor, directly blocking the Epithelial Na^+ Channel ( ENaC) in the late distal tubule and collecting duct. By preventing the reabsorption of sodium at this final site, it also reduces the driving force for K^+ secretion, mechanistically resulting in potassium-sparing action that influences the increased K^+ excretion induced by the upstream loop mechanism.

Summary of Physiological Effect: The synergistic action on these two independent targets maximizes the excretion of salt and water, resulting in a pronounced reduction in ECFV while influencing the distribution of potassium ions.

Dosage and Administration Information

How to Use Salidur: Official Administration Guidelines

Salidur is a fixed-dose combination medication intended for oral administration as tablets. The official usage guidelines outline a specific procedural structure for administration, dose management, and long-term scheduling based on standardized clinical and pharmaceutical guidelines.

Administration Scope

Feature	Official Instruction
Route of administration	Oral administration (for tablets).
Dosing schedule	The dose is individualized, beginning low and being titrated until the necessary diuretic effect is achieved. Increments of the Furosemide component should be administered no sooner than 6 to 8 hours after the preceding dose.
Timing in relation to meals (if applicable)	Recommended to be taken on an empty stomach and with sufficient liquid.
Special procedural conditions	The medication must be administered in the morning to avoid interference with sleep due to nocturnal diuresis. Administration must be separated by at least 2 hours from certain medications (e.g., sucralfate) to maintain proper absorption.
Age-group administration rules	Older Adults: Dose selection must be cautious, starting at the low end of the dosing range, and titrated to the required response.
Missed-dose rules	If a dose is missed, it must be skipped if it is near the time for the next scheduled dose; the dose should never be doubled.

Resulting Procedural Structure

Official step sequence:

The tablets are administered orally, preferably on an empty stomach, during the morning hours.
The dose is titrated based on response, with a required minimum of 6 to 8 hours between dose adjustments, if needed.
If a dose is missed, it must be skipped if close to the next scheduled time; the dose should never be doubled.

Connection to the overall use protocol:

The protocol is structured around achieving an individualized, effective dosage while mitigating disruptive effects and maintaining necessary clinical oversight. The cautious titration principle for dosing, coupled with a strict morning-priority schedule, defines the regimen. Furthermore, the use protocol specifies that the medication may be used as long-term therapy or for short-term, intermittent use for fluid mobilization.

Recent Clinical Evidence

Research Evidence: Overview of Clinical Studies for Salidur

This section summarizes the research that authoritative bodies rely on, focusing on the types of studies conducted, the populations examined, and the specific outcomes researchers measured for the components of Salidur in major clinical situations.

Evidence for Fluid Overload in Congestive Heart Failure

The research base exploring the fluid-removing component of Salidur has often involved Randomized Controlled Trials (RCTs) and Systematic Reviews focused on patients managing heart failure. The primary endpoints measured were outcomes related to physical discomfort, specifically research examined patient-reported outcomes describing perceived discomfort like swelling (edema) and the change in body weight or degree of congestion. Outcomes reflecting daily functioning or activity level were also measured, alongside blood electrolyte levels, including potassium.

Research so far indicates that potent fluid-removal agents like the Furosemide component was studied in research exploring fluid accumulation in adults with chronic heart failure. Additionally, studies of the combination’s components reported that the inclusion of the potassium-sparing agent (Triamterene) reported patterns related to measured changes in potassium levels compared to using the loop diuretic component alone.

Evidence for Edema in Renal and Liver Diseases

Research has examined the use of the medicine’s components in conditions associated with functional limitations, such as fluid retention linked to certain liver or chronic kidney conditions. These studies monitored outcomes related to systemic or functional imbalance, such as urine volume and the excretion rates of salt and electrolytes. The populations included adults with fluid overload and specific conditions such as nephrotic syndrome. The combination approach, utilizing both active components, was observed in studies evaluating temporary physiological imbalance.

What Remains Uncertain About the Research for Salidur

Evidence highlights what is known—and what is still uncertain—about this therapeutic combination. Follow-up durations were limited in many older RCTs, meaning long-term effects on major cardiovascular events or survival are not fully established. Research indicates that the measured response to the potent fluid-removal agent was observed to vary depending on the degree of underlying disease, such as advanced renal failure or low blood protein levels. Research is ongoing to better understand these variables.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Salidur (FAQ)

Q: How should I store this medication?

A: According to the official product information, Salidur should be stored at controlled room temperature, typically between 20 C to 25 C. It is indicated that the medication must be kept away from moisture and out of the reach of children. Refer to the product label for the most specific and accurate storage instructions.

Q: What if I miss a dose?

A: The labeling information indicates that if a dose of Salidur is missed, it can be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the regulatory instructions suggest skipping the missed dose and taking the next dose at the regular time. The official documentation also cautions against taking two doses at once to make up for a missed dose.

Q: Can I drink alcohol while taking this?

A: Official warnings and precautions sections advise that the use of alcohol should be avoided or limited while taking Salidur. Combining Salidur with alcohol may potentially increase the risk of certain side effects, such as drowsiness or dizziness. Specific guidance on alcohol use is detailed in the patient information leaflet.

Q: Is it safe long-term?

A: Safety information for Salidur is derived from clinical trials, which cover a specific, defined duration of use. The clinical data available details the risks and benefits observed during those studies. Assessment of individual risks and benefits is necessary for use that extends beyond the timeframes studied in regulatory research.

Q: Can children 2 years old use it?

A: The official product information specifies the approved age groups for this medication under the Pediatric Use section. Salidur is only approved for use in adults and is not approved for use in pediatric patients under the age of [Specific Age or stating that it is not approved for pediatric use]. Administration of this medication to children should only occur as directed by a healthcare professional.

How should Salidur be stored and disposed of?

How to Store and Dispose of Salidur?

Salidur (Furosemide and Triamterene) tablets must be stored according to official regulatory guidelines to maintain potency and stability. The required environment is Controlled Room Temperature, typically defined as 20 C to 25 C (68 F to 77 F), with protection from moisture. The medication must be kept in its original container and the lid must remain tightly closed when not in use.

Child-Safety and Disposal Rules

As with all prescription medications, it is mandatory to keep Salidur out of the sight and reach of children.

For disposal of unused or expired tablets, official guidelines recommend using a drug take-back program. If this is unavailable, the medicine should be mixed with an unappealing substance, sealed in a bag, and then discarded with household trash. Do not flush Salidur down a toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Spain

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z